Piramal Swasthya and The Rockefeller Foundation announce partnership to accelerate India's public health transformation
Express Pharma|January 1-15, 2020
Collaboration will harness innovative digital technology to support the Government of India’s vision to provide quality healthcare for all
Piramal Swasthya and The Rockefeller Foundation announce partnership to accelerate India's public health transformation

Piramal Swasthya Management and ResearchInstitute, the primary healthcare initiative of Piramal Foundation, and The Rockefeller Foundation today announced a strategic partnership to align with and support the Government of India’s vision to ensure Universal Health Coverage. In the initial stages, the partnership aims to set a global example by leveraging digital technology to reduce preventable deaths amongst mothers and children living in Aspirational Districts and tribal areas.

The Piramal Swasthya and Rockefeller teams will be working closely with the government on building cutting-edge primary health innovations and scaling them through policy interventions. The partnership will strengthen healthcare systems by integrating technologies such as artificial intelligence for evidence-based decision making. The idea is to save maternal and child deaths by providing appropriate and timely insights leading to effective policymaking and implementation of focused interventions.

The Piramal-Rockefeller partnership focuses on five of the 25 Aspirational Districts that are mentored by NITI Aayog. They are also part of the 117 Aspirational Districts identified by the Government of India as having urgent health and development needs. Many residents of these districts are members of tribal populations, who have significantly worse health outcomes than non-tribal populations. The maternal mortality rate in India is 122 deaths per 100,000 live births, while in the tribal communities it is even higher. Similarly, other health indicators such as infant mortality rates, child malnutrition rates, and incidence of malaria and tuberculosis are much higher among tribal communities than the general population.

At the outset, the PiramalRockefeller partnership will focus on two main streams of work:

Bu hikaye Express Pharma dergisinin January 1-15, 2020 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

Bu hikaye Express Pharma dergisinin January 1-15, 2020 sayısından alınmıştır.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.

EXPRESS PHARMA DERGISINDEN DAHA FAZLA HIKAYETümünü görüntüle
Achieving Aatmanirbharta In APIs Are We On The Right Track?
Express Pharma

Achieving Aatmanirbharta In APIs Are We On The Right Track?

As India gears up to celebrate its 75th Independence Day, self reliance in APIs remains a key goal for the pharma sector. AatmaNirbharta will be crucial for the sector as it continues to protect the country from the existing and emerging health threats

time-read
9 dak  |
August 2021
Yokogawa launches OpreX Data Model Broker
Express Pharma

Yokogawa launches OpreX Data Model Broker

A plant data transformation platform, OpreX automatically verifies discrepancies and inconsistencies in data to improve efficiency in plant construction and operation

time-read
2 dak  |
August 2021
Understanding the nuances of generics injectables
Express Pharma

Understanding the nuances of generics injectables

At a webinar, explaining the West Pharma's AccelTRA Components Program, industry experts explained why the use of glass vials and stoppers as primary container closure systems (CCS) has become crucial

time-read
6 dak  |
August 2021
Trending in nutraceuticals: Science meets sustainability
Express Pharma

Trending in nutraceuticals: Science meets sustainability

Zeljko Pockaj, Vice President, Global Pharmaceutical Industry, mentions the key trends that are believed to drive innovations and formulations for nutraceuticals’ development around the globe

time-read
3 dak  |
August 2021
The growth of e-pharmacies in India
Express Pharma

The growth of e-pharmacies in India

Rahul Nath Choudhury, Research fellow, ICWA, explains what motivates people in the pharma industry to invest into e-pharmacies, along with various other growth factors associated with these

time-read
4 dak  |
August 2021
Xylitol and Maltitol: Low-calorie sugar alternatives
Express Pharma

Xylitol and Maltitol: Low-calorie sugar alternatives

Polyols like Xylitol and Maltitol offer important health benefits. Unlike general sugar-free sweeteners, these do not have any bitter-after taste

time-read
4 dak  |
August 2021
Single-use TC gaskets and their importance
Express Pharma

Single-use TC gaskets and their importance

Depending on the application, gaskets are manufactured by different types of Material of Construction (MOC) such as Silicone, EPDM, Viton (FKM), Nitrile, Neoprene, PTFE, etc.

time-read
2 dak  |
August 2021
It's important to enhance customer experience so that existing customers are more loyal
Express Pharma

It's important to enhance customer experience so that existing customers are more loyal

Sheshgiri Kamath, CEO and co-founder, Kapture CRM, expands on why it is important for pharma companies to enhance customer experience, and how the right CRM solution can help companies to identify, address and manage customer expectations more effectively, in an interaction with Viveka Roychowdhury

time-read
5 dak  |
August 2021
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice
Express Pharma

From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice

Arun Kedia, Managing Director,VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across various medical therapies ranging from HIV to cancer to COVID-19 treatment

time-read
4 dak  |
August 2021
Ensuring pharma compliance with testo data loggers
Express Pharma

Ensuring pharma compliance with testo data loggers

Testo data loggers can be used to test the optimum conditions for specific products or surroundings

time-read
2 dak  |
August 2021